Yin, Tao <br/><br/>
Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator.  [electronic resource] 

 -  Scientific reports  Jan 2016 
 - 19534 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep19534  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptive Immunity--drug effects<br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Humans<br/>Immunologic Factors--pharmacology<br/>Immunomodulation--drug effects<br/>Inflammation Mediators--metabolism<br/>Lymphocyte Depletion<br/>Macrophages--drug effects<br/>Mice<br/>Neoplasm Metastasis<br/>Neovascularization, Pathologic<br/>Sulindac--pharmacology<br/>T-Lymphocyte Subsets--drug effects<br/>Tumor Burden--drug effects<br/>Tumor Microenvironment--drug effects